Featured Speakers
Ajay Sheshadri MD
Associate Professor
MD Anderson Cancer Center
Alit Stark-Inbar
PhD, Vice President Medical Information
Theranica
Anita Burrell
Founder
ANITA BURRELL CONSULTING LLC
Cassie Holt
PhD, MPH, CPH, Health Outcomes Associate Director – East, Medical Affairs
Novo Nordisk
Christine MacCracken
Senior Director, Head Patient Strategies and Solutions
Janssen
Claire Hague
Head of Real World Evidence and Value Based Healthcare (EMEA)
JANSSEN
Hayley Belli
Assistant Professor, Biostatistics, Department of Population Health
NYU Grossman School of Medicine
Jittrakul Leartsakulpanitch
Vice President, Global Market Access and Analytics
Johnson & Johnson
Juliette Chen
PhD., Director, Global Evidence and Outcomes
Takeda
Kelly McNeil-Posey
Director, HEOR
Alexion Pharmaceuticals
Laura Esserman
M.D., Director
Carol Franc Buck Breast Care Center University of California, San Francisco ( UCSF )
Lee Severson
Director, Regulatory Affairs
Amryt Pharma
Melissa Hagan
Director, Medical Affairs HEOR/RWE/Publications
Mitsubishi Tanabe Pharma America, Inc.
Mike Rousselle
Vice President of Data Product
OptimizeRx
Oscar Segurado
MD PhD, Chief Medical Officer
ASC Therapeutics
Rahul Bhambri
Senior Medical Director, US Medical Affairs
Pfizer Rare Disease
Sarah Blankstein
Associate
Ropes & Gray
Sheena Thakkar
Manager, Global HEOR
Pfizer
Shelly Ikeme
Global Head of Health Economics & Market Access
Acclarent, Mentor & Cerenovus Johnson & Johnson Medical Device
Shuvayu Sen
VP and Head Value Evidence and Real World Evidence
Otsuka Pharmaceutical Companies
Tom Watson
Chief Operating Officer
Bionical Emas